Autoimmune Diseases Associated with Lupus
Patients with systemic lupus erythematosus (SLE) frequently develop other autoimmune conditions, with thyroid disorders being the most common (10.5%), followed by Sjögren's syndrome (2.8-7%), rheumatoid arthritis (0.4-4%), autoimmune hepatitis (2.2-4.7%), systemic sclerosis (0.2%), and inflammatory bowel disease. 1, 2, 3
Most Common Co-occurring Autoimmune Diseases
Autoimmune Thyroid Disease (Most Prevalent)
- Thyroid disorders represent the most frequent autoimmune comorbidity in SLE patients, affecting approximately 10.5% of cases 1
- Hashimoto's thyroiditis is more common than Graves' disease in this population 1, 3
- Regular thyroid function screening is warranted given this strong association 3
Sjögren's Syndrome
- Occurs in 2.8-7% of SLE patients, characterized by lymphocytic infiltration of lacrimal and salivary glands causing dry eyes and dry mouth 1, 2, 3
- Can present as secondary Sjögren's syndrome in the context of SLE 2, 3
- Patients have increased risk for lymphoproliferative disorders, with approximately 5% developing lymphoma 3
- Co-management with rheumatology is essential due to potential systemic complications 3
Rheumatoid Arthritis
- Develops in approximately 0.4-4% of SLE patients 1
- More commonly occurs in older SLE patients compared to younger patients 1
- Immunosuppressive therapy benefits both conditions and prevents joint deformity 1
Autoimmune Hepatitis (AIH)
- Approximately 2.2-2.8% of SLE patients develop AIH, while conversely 2.7-4.7% of AIH patients have concurrent SLE 1
- SLE patients with elevated liver enzymes should be evaluated for AIH, as 19.4% of those with hepatic abnormalities have concurrent AIH 1
- Patients with both conditions demonstrate higher IgG levels and may have worse prognosis 1
- Complications can include myocarditis and thrombotic thrombocytopenic purpura 1
Systemic Sclerosis (Scleroderma)
- Occurs in approximately 0.2% of SLE patients 1
- When present, particularly in juvenile-onset scleroderma, pulmonary arterial hypertension can develop in <10% of cases before age 21, though it can be fatal when it occurs 1
- Primary biliary cholangitis occurs in 8% of limited cutaneous systemic sclerosis cases 3
Inflammatory Bowel Disease
- IBD occurs in 2-11.4% of SLE patients, with ulcerative colitis being more common than Crohn's disease 1
- Conversely, 3.7-11.4% of IBD patients develop SLE 1
Clinical Implications and Monitoring
Screening Recommendations
- Patients with SLE should be monitored for development of additional autoimmune disorders, particularly thyroid disease, Sjögren's syndrome, and rheumatoid arthritis 2, 3
- Antinuclear antibody profiles and specific autoantibodies should be assessed at baseline and when new symptoms emerge 2
- Regular assessment for dry eyes, dry mouth, joint symptoms, and thyroid dysfunction is warranted 3
Important Clinical Pitfalls
- The presence of one autoimmune condition substantially increases risk for others—this is termed the "kaleidoscope of autoimmunity" 4
- Autoimmune diseases share genetic backgrounds, particularly within the major histocompatibility complex, explaining their clustering 4
- Environmental triggers (drugs, viral infections, UV radiation) can precipitate multiple autoimmune conditions in genetically susceptible individuals 4
- Complement deficiencies can present with lupus-like disease, highlighting the complex relationship between immunodeficiency and autoimmunity 2
Management Considerations
- Immunosuppressive therapy used for SLE often benefits concurrent autoimmune conditions 1
- Hydroxychloroquine remains standard of care for SLE and may provide benefit for associated autoimmune manifestations 5, 6
- When multiple autoimmune conditions coexist, treatment must balance disease control across all affected systems while minimizing cumulative immunosuppression-related complications 1
- Patients with primary immunodeficiencies like selective IgA deficiency have increased risk of developing autoimmune conditions and require appropriate screening 2